NIOX Group (LON:NIOX) Trading Down 0.6% – Here’s What Happened

NIOX Group Plc (LON:NIOX)’s stock price dropped 0.6% during trading on Thursday . The company traded as low as GBX 67.55 and last traded at GBX 68.20. Approximately 202,489 shares changed hands during trading, a decline of 76% from the average daily volume of 831,375 shares. The stock had previously closed at GBX 68.60.

NIOX Group Trading Down 0.6%

The stock has a market capitalization of £287.03 million, a P/E ratio of 41.59 and a beta of 0.92. The firm’s 50 day moving average price is GBX 61.63 and its 200 day moving average price is GBX 61.16. The company has a debt-to-equity ratio of 1.36, a current ratio of 3.81 and a quick ratio of 1.94.

Insider Activity

In other NIOX Group news, insider Sarah Duncan bought 34,127 shares of NIOX Group stock in a transaction dated Friday, May 29th. The shares were purchased at an average cost of GBX 59 per share, with a total value of £20,134.93. Company insiders own 5.11% of the company’s stock.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.